Clinical Trials on 实体转移瘤 in China
总计3448个结果
-
Jiangsu Simcere Pharmaceutical Co., Ltd.未知
-
Second Affiliated Hospital of Soochow University尚未招聘
-
Kohei ShitaraOno Pharmaceutical Co. Ltd; Bayer Yakuhin, Ltd.完全的
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Jiangsu vcare pharmaceutical technology co., LTD招聘中
-
Chinese PLA General HospitalUTC Therapeutics Inc.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
BeBetter Med IncXiangya Hospital of Central South University招聘中
-
Zai Lab (Shanghai) Co., Ltd.Mirati Therapeutics Inc.主动,不招人
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.尚未招聘
-
Avistone Biotechnology Co., Ltd.Zhejiang Cancer Hospital; Henan Cancer Hospital; Hunan Cancer Hospital; Peking University Cancer... 和其他合作者招聘中
-
Chinese PLA General HospitalWuxi Sinotide New Drug Discovery Institutes招聘中
-
Shanghai East HospitalImbioray (Hangzhou) Biomedicine Co., Ltd.招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.招聘中
-
Jiangsu vcare pharmaceutical technology co., LTD完全的
-
Fujian Cosunter Pharmaceutical Co. Ltd未知实体瘤 | C-Met Mutation-Related Tumors中国
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.; Simcere Zaiming招聘中
-
Calico Life Sciences LLCAbbVie招聘中
-
Shanghai Miracogen Inc.招聘中
-
Jiangsu Simcere Pharmaceutical Co., Ltd.招聘中具有 NTRK、ROS1 或 ALK 基因融合的晚期或转移性实体瘤中国
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLC招聘中